NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/19/2019
Back to search
Official data from USPTO
XEL PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
XEL PHARMACEUTICALS
ST13
US500000077604551Class
42
Filing
77604551
Registration
3785659
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
07/19/2019
Trademark type
Word
Nice classes
42
Filing date
10/30/2008
Registration date
05/04/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/19/2019
Last transaction
07/19/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2008-01-00
First use in commerce
2008-06-00
Drawing code
4
Owner type
03
Owner location
Draper, UT
Examiner
LORENZO, KATHLEEN H
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Xel Pharmaceuticals, Inc.
Xel Herbaceuticals, Inc.
Representatives
XEL PHARMACEUTICALS, INC.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of drug delivery systems
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/19/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/19/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/19/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
06/12/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/04/2019
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
01/24/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/18/2017
ES8R
TEAS SECTION 8 RECEIVED
10/17/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/17/2016
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/28/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2016
ES8R
TEAS SECTION 8 RECEIVED
03/09/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/09/2016
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
07/19/2011
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
07/19/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
03/31/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/30/2010
ALIE
ASSIGNED TO LIE
03/30/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/29/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/15/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/15/2010
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/18/2010
IUAF
USE AMENDMENT FILED
02/11/2010
EISU
TEAS STATEMENT OF USE RECEIVED
02/11/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/11/2009
PUBO
PUBLISHED FOR OPPOSITION
05/19/2009
NPUB
NOTICE OF PUBLICATION
04/29/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/10/2009
ALIE
ASSIGNED TO LIE
04/10/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2009
CNRT
NON-FINAL ACTION MAILED
02/06/2009
CNRT
NON-FINAL ACTION WRITTEN
02/06/2009
DOCK
ASSIGNED TO EXAMINER
01/31/2009
MPMK
NOTICE OF PSEUDO MARK MAILED
11/04/2008
NWAP
NEW APPLICATION ENTERED
11/03/2008
Continuous trademark protection
Get notified about every new filing that threatens XEL PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.